SNCA

gene product
alpha-synuclein, NACP, PARK1, PARK4, PD1
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
493 antibodies from 22 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Novus Biologicals
38 antibodies
Biosensis Pty Ltd
3 antibodies
antibodies-online
149 antibodies
GeneTex
21 antibodies
Cell Signaling Technology, Inc
8 antibodies
Abnova Corporation
32 antibodies
Thermo Fisher Scientific Pierce
10 antibodies
Proteintech Group
1 antibody
Acris Antibodies GmbH
87 antibodies
Aviva Systems Biology
13 antibodies
Rockland Immunochemicals, Inc.
1 antibody
Abbiotec
2 antibodies
Creative Biomart
41 antibodies
PhosphoSolutions
2 antibodies
LifeSpan BioSciences, Inc.
45 antibodies
EMD Millipore
13 antibodies
Epitomics
3 antibodies
Everest Biotech
2 antibodies
Enzo Life Sciences
6 antibodies
Spring Bioscience
4 antibodies
GenWay
8 antibodies
Sigma-Aldrich
4 antibodies